TNF and systemic lupus erythematosus: Additionally, Bana et al. (21) and Barbarroja et al. (22) provided evidence that elevated levels of inflammatory and fibrosis markers, such as TNF-α and anti-CCP titers, were linked with proatherogenic profiles in SLE and RA patients, respectively.